• No results found

Diabetic Nephropathy (DN)

Diabetic nephropathy: recent advances in pathophysiology and challenges in dietary management

Diabetic nephropathy: recent advances in pathophysiology and challenges in dietary management

... lesions, diabetic nephropathy is now classified as diabetic kidney disease ...term diabetic chronic kidney disease (DCKD) was proposed to replace diabetic nephropathy to explain ...

5

Review Article Klotho in diabetes and diabetic nephropathy: a brief update review

Review Article Klotho in diabetes and diabetic nephropathy: a brief update review

... Klotho (KL) is originally identified as an anti- aging protein, but is subsequently discovered to have a multitude of biological effects [1]. KL is expressed in multiple tissues and organs, but by far, its highest ...

8

The association between interleukin-19 concentration and diabetic nephropathy

The association between interleukin-19 concentration and diabetic nephropathy

... [3]. Diabetic nephropathy (DN) is a major microvascular complication of diabetes melli- tus(DM), it is the leading cause of end-stage renal ...

6

The Role of Akt2 in the Protective Effect of Fenofibrate against Diabetic Nephropathy

The Role of Akt2 in the Protective Effect of Fenofibrate against Diabetic Nephropathy

... against diabetic nephropathy (DN) in type 1 diabetic (T1D) mice by upregulating the expression of fibroblast growth factor 21 (FGF21), leading to the activation of the Akt-mediated Nrf2 ...

15

TLR4 Polymorphisms (896A>G and 1196C>T) Affect the Predisposition to Diabetic Nephropathy in Type 2 Diabetes Mellitus

<p>TLR4 Polymorphisms (896A&gt;G and 1196C&gt;T) Affect the Predisposition to Diabetic Nephropathy in Type 2 Diabetes Mellitus</p>

... on diabetic nephropathy ...of DN in different studies. 42–47 Although, the small number of nephropathy (11%) should not rule out ...involving DN cases and diabetes as ...

7

Therapeutic Modalities in Diabetic Nephropathy: Future Approaches

Therapeutic Modalities in Diabetic Nephropathy: Future Approaches

... 2 DN patients [64]. In this study, 123 patients with DN and macroalbuminuria were ran- domized to either 32 mg daily of RTX or placebo for 1 year ...in DN (reduction in al- buminuria and prevention ...

14

Association between E469K polymorphism in the ICAM1 gene and the risk of diabetic nephropathy: a meta-analysis

Association between E469K polymorphism in the ICAM1 gene and the risk of diabetic nephropathy: a meta-analysis

... This meta-analysis followed the Cochrane Collaboration definition and PRISMA 2009 guidelines for meta-analysis and systematic review [22]. To identify eligible studies, we systematically searched PubMed, Embase, the ...

9

Comparative study of Dyslipidemia in Diabetic patients with Diabetic Nephropathy and Diabetic patients without Nephropathy

Comparative study of Dyslipidemia in Diabetic patients with Diabetic Nephropathy and Diabetic patients without Nephropathy

... Many epidemiologic studies examine the role of albuminuria and renal function on dyslipidemia in diabetic patients. A study of 200 Japanese patients with T2D investigated the lipoprotein alterations in ...

6

Study of urinary cyclophilin a level in diabetic nephropathy

Study of urinary cyclophilin a level in diabetic nephropathy

... Early studies suggested that approximately 80% of microalbuminuric type 1 diabetic patients would develop proteinuria [133-135]. However, more recent studies suggest that in approximately 30% of micro-albuminuric ...

123

Nitric oxide system and diabetic nephropathy

Nitric oxide system and diabetic nephropathy

... A broad spectrum of findings and issues has been amassed concerning the pathophysiology of the renal NO system in diabetes. Severe diabetes with profound insulinopenia can be viewed as a state of generalized NO ...

6

Ramipril inhibits AGE-RAGE-induced matrix metalloproteinase-2 activation in experimental diabetic nephropathy

Ramipril inhibits AGE-RAGE-induced matrix metalloproteinase-2 activation in experimental diabetic nephropathy

... DN: Diabetic nephropathy; ECM: Extracellular matrix; AGE: Advanced glycation end products; RAGE: Receptor for AGE; MMPs: Matrix metalloproteinases; RAS: Renin-angiotensin system; ACE: ...

9

Early urinary biomarkers of diabetic nephropathy in type 1 diabetes mellitus show involvement of kallikrein-kinin system

Early urinary biomarkers of diabetic nephropathy in type 1 diabetes mellitus show involvement of kallikrein-kinin system

... Urine has been shown to reflect many pathologic and physiologic conditions with the highest accuracy and sensitivity [5]. At the same time, diabetes is a profound metabolic disorder presenting with a variety of organ in- ...

10

Advanced glycation end products (AGEs) increase renal lipid accumulation: a pathogenic factor of diabetic nephropathy (DN)

Advanced glycation end products (AGEs) increase renal lipid accumulation: a pathogenic factor of diabetic nephropathy (DN)

... in DN include hyperfiltration and microalbuminuria followed by worsening of renal functions associated with cellular and extracellular derangements in both the glom- erular and the tubulointerstitial compartments ...

9

Interaction between ELMO1 gene polymorphisms and environment factors on susceptibility to diabetic nephropathy in Chinese Han population

Interaction between ELMO1 gene polymorphisms and environment factors on susceptibility to diabetic nephropathy in Chinese Han population

... of DN risk ...to DN. DN is the most common cause of ESRD and the most com- mon microvascular complication of diabetes mellitus ...of DN susceptibility [18, ...of DN, which has influence ...

7

Association of elevated glycosylated hemoglobin A1c with hyperfiltration in a middle-aged and elderly Chinese population with prediabetes or newly diagnosed diabetes: a cross-sectional study

Association of elevated glycosylated hemoglobin A1c with hyperfiltration in a middle-aged and elderly Chinese population with prediabetes or newly diagnosed diabetes: a cross-sectional study

... glucose; DN: Diabetic nephropathy; ESRD: End-stage renal disease; T2DM: Type 2 diabetes mellitus; DCCT-EDIC: Diabetes control and complications trial-epidemiology of diabetes interventions and ...

7

Thioredoxin-Interacting Protein as a Novel Potential Therapeutic Target in Diabetes Mellitus and Its Underlying Complications

<p>Thioredoxin-Interacting Protein as a Novel Potential Therapeutic Target in Diabetes Mellitus and Its Underlying Complications</p>

... Diabetic nephropathy (DN), is also one of the microvascular complications of ...countries. DN accounts for almost one- third of all cases that lead to renal disease and, with the global “ ...

9

Spectrum (characteristics) of patients with chronic kidney disease (CKD) with increasing age in a major metropolitan renal service

Spectrum (characteristics) of patients with chronic kidney disease (CKD) with increasing age in a major metropolitan renal service

... Data were extracted from the clinical records of partici- pants, both electronic and hardcopy, at the time point of consent and throughout the study period. Outcomes were sourced from a combination of these records and ...

10

C-reactive protein genetic variant is associated with diabetic retinopathy in Chinese patients with type 2 diabetes

C-reactive protein genetic variant is associated with diabetic retinopathy in Chinese patients with type 2 diabetes

... with diabetic nephropathy (DN) [18,19] and DR [15,20] in the last decade, raising the possibility that the increase of CRP may be an early event or even one of driving forces in the development of ...

7

Glycated albumin and the risk of micro- and macrovascular complications in subjects with Type 1 Diabetes

Glycated albumin and the risk of micro- and macrovascular complications in subjects with Type 1 Diabetes

... Conventionally, DN is defined as a progressive kidney disease characterized by persistent albuminuria, in- creased blood pressure, and a continuous decline in ...of diabetic nephropathy in a total of ...

8

Intrarenal microRNA signature related to the fibrosis process in chronic kidney disease: identification and functional validation of key miRNAs

Intrarenal microRNA signature related to the fibrosis process in chronic kidney disease: identification and functional validation of key miRNAs

... Background: Though the roles of microRNAs (miRNAs) in renal diseases have been extensively investigated, a thorough screening and comparison of miRNAs among different types of chronic kidney disease (CKD) has never been ...

13

Show all 8554 documents...

Related subjects